The Difference in All-Cause Mortality Between Allergic Bronchopulmonary Aspergillosis with and without Chronic Obstructive Pulmonary Disease

References

• Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70(3):270–277. doi:10.1136/thoraxjnl-2014-206291
   PubMed Web of Science ®Google Scholar
• Bains SN, Judson MA. Allergic bronchopulmonary aspergillosis. Clin Chest Med. 2012;33(2):265–281. doi:10.1016/j.ccm.2012.02.003
   PubMed Web of Science ®Google Scholar
• Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol. 2013;51(4):361–370. doi:10.3109/13693786.2012.738312
   PubMed Web of Science ®Google Scholar
• Ma YL, Zhang WB, Yu B, Chen YW, Mu S, Cui YL. Prevalence of allergic bronchopulmonary aspergillosis in Chinese patients with bronchial asthma. Chin J Tuberculosis Respir Dis. 2011;34(34):909–913.
   Google Scholar
• Jin JM, Liu XF, Sun YC. The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function. Respir Res. 2014;15:130. doi:10.1186/s12931-014-0130-1
   PubMed Web of Science ®Google Scholar
• Liu XF, Sun YC, Jin JM, Li R, Liu Y. Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of 3 cases. Chin J Tuberculosis Respir Dis. 2013;36(10):5.
   Google Scholar
• Agarwal RH, Basanta G, Dheeraj A, et al. Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? Med Mycol. 2010;48(7):988–994. doi:10.3109/13693781003743148
   PubMed Web of Science ®Google Scholar
• Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1277–1284. doi:10.1164/ajrccm.162.4.9906120
   PubMed Web of Science ®Google Scholar
• Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: cystic fibrosis foundation consensus conference. Clin Infect Dis. 2003;37(Suppl 3):S225–S264. doi:10.1086/376525
   PubMed Web of Science ®Google Scholar
• Agarwal R, Srinivas R, Jindal SK. Allergic bronchopulmonary aspergillosis complicating chronic obstructive pulmonary disease. Mycoses. 2008;51(1):83–85. doi:10.1111/j.1439-0507.2007.01432.x
   PubMed Web of Science ®Google Scholar
• Muthu V, Prasad KT, Sehgal IS, Dhooria S, Aggarwal AN, Agarwal R. Obstructive lung diseases and allergic bronchopulmonary aspergillosis. Curr Opin Pulm Med. 2021;27(2):105–112. doi:10.1097/MCP.0000000000000755
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi:10.1111/resp.12660
   PubMed Web of Science ®Google Scholar
• Tiew PY, Ko FWS, Pang SL, et al. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD. Eur Respir J. 2020;56(2):2000418. doi:10.1183/13993003.00418-2020
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Agbetile J, et al. Aspergillus fumigatus during stable state and exacerbations of COPD. Eur Respir J. 2014;43(1):64–71. doi:10.1183/09031936.00162912
   PubMed Web of Science ®Google Scholar
• Sorino C, Pedone C, Scichilone N. Fifteen-year mortality of patients with asthma-COPD overlap syndrome. Eur J Intern Med. 2016;34:72–77. doi:10.1016/j.ejim.2016.06.020
   PubMed Web of Science ®Google Scholar
• Lu HW, Mao B, Wei P, et al. The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis. Clin Respir J. 2020;14(2):140–147. doi:10.1111/crj.13111
   PubMed Web of Science ®Google Scholar
• Agarwal R, Garg M, Aggarwal AN, Saikia B, Gupta D, Chakrabarti A. Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes. Respir Med. 2012;106(7):942–947. doi:10.1016/j.rmed.2012.03.001
   PubMed Web of Science ®Google Scholar
• Zeng YY, Xue XM, Cai H, et al. Clinical characteristics and prognosis of allergic bronchopulmonary aspergillosis: a retrospective cohort study. J Asthma Allergy. 2022;15:53–62. doi:10.2147/JAA.S345427
   PubMed Web of Science ®Google Scholar
• Agarwal R, Aggarwal AN, Sehgal IS, Dhooria S, Behera D, Chakrabarti A. Utility of IgE (total and Aspergillus fumigatus specific) in monitoring for response and exacerbations in allergic bronchopulmonary aspergillosis. Mycoses. 2016;59(1):1–6. doi:10.1111/myc.12423
   PubMed Web of Science ®Google Scholar
• Muthu V, Sehgal IS, Prasad KT, et al. Allergic bronchopulmonary aspergillosis (ABPA) sans asthma: a distinct subset of ABPA with a lesser risk of exacerbation. Med Mycol. 2020;58(2):260–263. doi:10.1093/mmy/myz051
   PubMed Web of Science ®Google Scholar
• Muthu V, Sehgal IS, Prasad KT, et al. Epidemiology and outcomes of allergic bronchopulmonary aspergillosis in the elderly. Mycoses. 2022;65(1):71–78. doi:10.1111/myc.13388
   PubMed Web of Science ®Google Scholar
• Wang SJ, Zhang J, Zhang CP, Shao CZ. Clinical characteristics of allergic bronchopulmonary aspergillosis in patients with and without bronchiectasis. J Asthma. 2021;58(1):1–7. doi:10.1080/02770903.2019.1656230
   PubMed Web of Science ®Google Scholar
• Tiew PY, Lim AYH, Keir HR, et al. High frequency of allergic bronchopulmonary aspergillosis in bronchiectasis-COPD overlap. Chest. 2022;161(1):40–53. doi:10.1016/j.chest.2021.07.2165
   PubMed Web of Science ®Google Scholar
• Asthma Group of the Respiratory Diseases Branch of the Chinese Medical Association. Experts consensus on diagnosis and treatment of allergic bronchopulmonary aspergillosis. Natl Med J China. 2017;34:2650–2656.
   Google Scholar
• Chronic Obstructive Pulmonary Disease Group of the Respiratory Diseases Branch of the Chinese Medical Association. The guidelines for the diagnosis and treatment of COPD (2013 revised edition). Chin J Front Med Sci. 2014;2:67–80.
   Google Scholar
• Lv XD. The diagnostic criteria of the guidelines for the prevention and treatment of bronchial asthma (2016 edition). Chin J Tuberculosis Respir Dis. 2016;39(9):675–697.
   Google Scholar
• Adult Bronchiectasis Diagnosis and Treatment Expert Consensus Writing Group. Expert consensus on diagnosis and treatment of adult bronchiectasis (2012 edition). Chin J Crit Care Med. 2012;5(5):20–30.
   Google Scholar
• Hansell DM, Strickland B. High-resolution computed tomography in pulmonary cystic fibrosis. Br J Radiol. 1989;62(733):1–5. doi:10.1259/0007-1285-62-733-1
   PubMed Web of Science ®Google Scholar
• Tiew PY, Dicker AJ, Keir HR, et al. A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD. Eur Respir J. 2021;57(3):2002050. doi:10.1183/13993003.02050-2020
   PubMed Web of Science ®Google Scholar
• Wang MY, Qian YJ, Lin L, Wang HM. Allergic bronchopulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of 10 cases. Chin J Tuberculosis Respir Dis. 2019;42(7):543–545.
   Google Scholar
• Zhang MQ, Gao JM. Clinical analysis of 77 patients with allergic bronchopulmonary aspergillosis in Peking Union Medical College Hospital. Acta Acad Med Sinicae. 2017;39(3):352–357. doi:10.3881/j.issn.1000-503X.2017.03.009
   Google Scholar
• Zou MF, Li S, Yang Y, et al. Clinical features and reasons for missed diagnosis of allergic bronchopulmonary aspergillosis. Natl Med J China. 2019;99(16):1221–1225. doi:10.3760/cma.j.issn.0376-2491.2019.16.006
   Google Scholar
• Groenewegen KH, Postma DS, Hop WCJ, Wielders PLML, Schlösser NJJ, Wouters EFM. Increased systemic inflammation is a risk factor for COPD exacerbations. Chest. 2008;133(2):350–357. doi:10.1378/chest.07-1342
   PubMed Web of Science ®Google Scholar
• Lonergan M, Dicker AJ, Crichton ML, et al. Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD. Respir Res. 2020;21(1):166. doi:10.1186/s12931-020-01436-7
   PubMed Web of Science ®Google Scholar
• Yao CY, Liu XL, Tang Z. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2285–2290. doi:10.2147/COPD.S141760
   PubMed Web of Science ®Google Scholar
• Xiong W, Xu M, Zhao YF, Wu XL, Pudasaini B, Liu JM. Can we predict the prognosis of COPD with a routine blood test? Int J Chron Obstruct Pulmon Dis. 2017;12:615–625. doi:10.2147/COPD.S124041
   PubMed Web of Science ®Google Scholar
• Patterson K, Strek ME. Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc. 2010;7(3):237–244. doi:10.1513/pats.200908-086AL
   PubMedGoogle Scholar
• Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest. 2006;130(2):442–448. doi:10.1378/chest.130.2.442
   PubMed Web of Science ®Google Scholar
• Kumar R, Chopra D, Chopra RD. Evaluation of allergic bronchopulmonary aspergillosis in patients with and without central bronchiectasis. J Asthma. 2002;39(6):473–477. doi:10.1081/JAS-120004905
   PubMed Web of Science ®Google Scholar
• Denning DW, Pashley C, Hartl D, et al. Fungal allergy in asthma-state of the art and research needs. Clin Transl Allergy. 2014;4:14. doi:10.1186/2045-7022-4-14
   PubMed Web of Science ®Google Scholar
• Ma YL. The use of biological agents for the treatment of allergic bronchopulmonary aspergillosis. Chin J Tuberculosis Respir Dis. 2019;42(11):864–868. doi:10.3760/cma.j.issn.1001-0939.2019.11.017
   Google Scholar